Megamenu Mobile Button Submenu

The BIO World Congress Start-Up Stadium provides high visibility to early stage emerging companies to present in front of VC investors, analysts, angel investors, and strategists. Emerging companies will share their new technologies and value proposition through formal 15-minute presentations. BIO World Congress offers investors discounted registration rates.

Why Participate in Start-Up Stadium?

Networking Opportunity

•Connecting with the right people is essential for building relationships and organizing deals

•The BIO One-on-One Partnering™ system provides industrial biotechnology companies with the opportunity to schedule private meetings with investors, and industry business development and licensing executives

• Start-Up Stadium brings the right people together, while ensuring there is a pleasant mix of industrial biotechnology attendees and a low percentage of service providers

High Quality Content

•An elite group of private and early stage emerging industrial biotechnology companies will present their new technologies, accomplishments, value propositions, business case, and exit strategies.

•Presentations provide an opportunity for investors to learn about the latest technologies and connect with executives from innovative companies

•A panel discussion by leading investment firms covering the most recent industrial biotechnologies, financial strategies, useful best practices for improving your business, while also identifying trends, threats and opportunities on the horizon. Conference attendees will hear new technologies and unique perspectives on building the biobased economy, providing insights into the latest business developments

Business Development Insight

•Conference attendees will hear new technologies and unique perspectives on building the biobased economy, providing insights into the latest business developments

*Qualified investors are defined as institutional, private equity, angel and venture investors with funds on-hand, whose primary activity is direct investment in research and development companies (e.g., hedge fund, mutual fund, or venture fund). Equity research analysts from investment banking institutions and buy-side analysts also qualify as investors. Qualified investors receive a reduced registration fee to attend the entire conference.

Oxford Biotrans Limited is a University of Oxford spin-out company that develops and commercializes enzymatic process technologies that yield high-value chemical compounds.

Kalion, Inc. is an early stage industrial biotech company focused on providing low-cost access to glucaric acid and S-3-hydroxybutyrolactone (3-HBL) using traditional and green fermentation technology.

Triton Algae Innovationsis devoted to the idea of providing its healthy and nutritious green algae as a sustainabile and affordable source of alternative protein to help meet increasing domestic and global demand.

Syngulonis a synthetic biology startup developing original genetic technologies using bacteriocins in order to improve microbial fermentation.

Steeper Energy focuses on the development of advanced biofuels from low-value biomass, such as residues and wastes from the agriculture and forest industries.